BRILLANTI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 2.001
EU - Europa 1.198
AS - Asia 523
AF - Africa 75
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.803
Nazione #
US - Stati Uniti d'America 1.993
GB - Regno Unito 381
CN - Cina 205
SE - Svezia 188
DE - Germania 167
SG - Singapore 161
IT - Italia 159
IN - India 105
UA - Ucraina 69
IE - Irlanda 59
RU - Federazione Russa 46
FR - Francia 43
EE - Estonia 32
ZA - Sudafrica 30
VN - Vietnam 25
TG - Togo 21
BE - Belgio 17
CH - Svizzera 13
JO - Giordania 11
NG - Nigeria 11
BG - Bulgaria 10
CI - Costa d'Avorio 10
CA - Canada 7
IR - Iran 7
JP - Giappone 6
GR - Grecia 4
NL - Olanda 4
SC - Seychelles 3
CZ - Repubblica Ceca 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
FI - Finlandia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.803
Città #
Southend 348
Fairfield 274
Chandler 167
Ashburn 148
Singapore 141
Wilmington 134
Ann Arbor 121
Woodbridge 112
Houston 111
Seattle 98
Princeton 79
Cambridge 78
Dublin 58
Boardman 42
Jacksonville 42
Nanjing 36
Westminster 34
Bologna 31
Padova 29
New York 26
Dong Ket 25
Saint Petersburg 22
Lomé 21
Medford 20
Santa Clara 20
Beijing 17
Brussels 17
Bremen 16
Dearborn 16
San Diego 15
Shenyang 15
Berlin 14
Falls Church 12
Florence 12
Monmouth Junction 12
Abeokuta 11
Amman 11
Abidjan 10
Sofia 10
Tianjin 10
Jinan 9
Mülheim 9
Redmond 9
Bern 8
Guangzhou 8
Redwood City 8
Changsha 7
Dolo 7
Norwalk 7
Turin 7
Hebei 6
Jiaxing 6
Milan 6
Nanchang 6
Tokyo 6
Ardabil 5
Des Moines 5
Forlì 5
Fuzhou 5
Lake Forest 5
Siena 5
Wuhan 5
Chengdu 4
Haikou 4
Kunming 4
Toronto 4
Washington 4
Buffalo 3
Casalecchio di Reno 3
Hangzhou 3
Imola 3
Leawood 3
Mahé 3
Ningbo 3
Shanghai 3
Taizhou 3
Xi'an 3
Aachen 2
Amsterdam 2
Andover 2
Bari 2
Bühl 2
Castrop-rauxel 2
Foshan 2
Kilburn 2
Lessolo 2
London 2
Moscow 2
Mountain View 2
Qingdao 2
Radeberg 2
San Giovanni Lupatoto 2
Suzhou 2
Velletri 2
Athens 1
Auckland 1
Blanding 1
Brampton 1
Changchun 1
Chongqing 1
Totale 2.649
Nome #
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 141
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations. 134
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 132
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 126
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 123
Ribavirin for chronic hepatitis C: And the mystery goes on. 122
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 122
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 121
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 119
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 115
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C. 114
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 114
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 110
Terapia cellulare in Epatologia 108
null 107
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 107
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 107
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 106
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. 100
Severe acute autoimmune hepatitis after natalizumab treatment. 97
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 96
null 96
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 95
Proctosigmoidite ulcerosa refrattaria e recidivante alla terapia topica trattata con beclometasone dipropionato orale 90
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 90
Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues. 84
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 84
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study. 80
Trattamento della Epatite da HCV 79
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 74
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 71
null 70
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 68
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT 66
La ribavirina nell'epatite cronica C: storia e segreti di un grande successo. 65
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 63
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 63
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy 62
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 59
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 48
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 41
Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression? 24
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project 22
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 1
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 1
Totale 3.917
Categoria #
all - tutte 10.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020729 0 0 0 49 95 96 128 120 109 58 33 41
2020/2021468 97 44 21 16 20 18 10 28 56 47 29 82
2021/2022829 42 39 33 53 71 49 15 39 30 47 291 120
2022/2023741 76 85 42 111 61 66 16 41 125 17 60 41
2023/2024240 12 49 16 17 32 51 10 9 26 4 1 13
2024/2025311 41 160 89 21 0 0 0 0 0 0 0 0
Totale 3.917